# OnCo record tomoki-todo (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/tomoki-todo/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "tomoki-todo" ;
  schema:name "Tomoki Todo"@en ;
  schema:description "Tomoki Todo built the triple-mutated herpes virus that became the first oncolytic virus approved in Japan, and ran the trial in recurrent glioblastoma behind that approval."@en ;
  schema:url <https://onco.cc/people/tomoki-todo/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://orcid.org/0000-0003-0523-8010>, <https://pubmed.ncbi.nlm.nih.gov/?term=Todo%20T%5BAuthor%5D%20oncolytic>, <https://www.ims.u-tokyo.ac.jp/imsut/en/> ;
  onco:tag "oncolytic-virus", "neuro-oncology", "japan" ;
  schema:jobTitle "Professor, Division of Innovative Cancer Therapy, Advanced Clinical Research Center, and Department of Surgical Neuro-Oncology, Institute of Medical Science, The University of Tokyo" ;
  schema:sameAs <https://orcid.org/0000-0003-0523-8010> ;
  onco:cancers <https://onco.cc/cancers/glioblastoma/> ;
  onco:technologies <https://onco.cc/technologies/oncolytic-virus/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-todo-g47delta-glioblastoma-natmed-2022/> .